The aim of the present review, therefore, is to analyze and summarize the recent relevant clinical literature on molecular markers of focal hypoxia with particular emphasis on the prognostic role of S100B protein and the GFAP in patients with stroke. The gene discussed is GFAP; the disease is stroke disorder.